Nicotine: Uses, Benefits, and Genetic Factors

1) Conditions Studied for Nicotine Treatment

Nicotine has been studied for a variety of conditions, including:

• Tobacco dependence and smoking cessation
• Attention-deficit/hyperactivity disorder (ADHD)
• Alzheimer's disease and cognitive decline
• Parkinson's disease
• Ulcerative colitis

2) Efficacy in Treating Conditions

Nicotine replacement therapies (NRT) are effective for smoking cessation, helping to reduce withdrawal symptoms and cravings. There is some evidence suggesting potential benefits in cognitive function for Alzheimer's patients, and it might have symptomatic relief for ulcerative colitis. The evidence for ADHD and Parkinson's disease is less clear, and more research is needed to determine its efficacy.

3) Health Benefits of Nicotine

Some potential health benefits of nicotine may include:

• Improvement in attention, memory, and cognitive function
• Reduced risk of weight gain after smoking cessation
• Neuroprotective effects that could potentially delay the onset of neurodegenerative diseases

4) Downsides of Nicotine

Despite its potential uses, nicotine also has significant downsides:

• Addictive properties leading to dependence
• Increased risk of cardiovascular diseases
• Potential for negative effects on fetal development when used during pregnancy
• Association with various types of cancer

5) Genetic Variations and Nicotine

Research has indicated that genetic variations can influence how individuals respond to nicotine:

Beneficial:

• Some genetic variants in nicotine receptors may make individuals more responsive to nicotine replacement therapies for smoking cessation.

Harmful:

• Other genetic variations may increase the risk of nicotine dependence and make quitting smoking more difficult.
• Genes related to the metabolism of nicotine can affect the rate at which it is processed and cleared from the body, impacting both the risk of addiction and the effectiveness of NRTs.

Nicotine Research Summary

The following summarizes various research findings focusing on the effects of nicotine:

• Nicotine has been found to affect several physiological functions, including hormone levels, body weight, and organ function.
• Studies indicate that nicotine can influence reproductive health, with impacts such as reduced testosterone production in Leydig cells and changes in testicular structure that could affect fertility.
• Nicotine metabolism is faster in women than in men, particularly among women using oral contraceptives. This may be due to the effects of sex hormones like estrogen.
• Research suggests that nicotine use can impair synaptic plasticity in the female rat hippocampus, potentially through disruption of estrogen signaling pathways.
• Chronic nicotine exposure has been linked to increased oxidative stress in various organs, but substances like taurine may mitigate this damage due to their antioxidant properties.
• Nicotine has been found to interact with other substances such as alcohol and caffeine, potentially influencing their effects on the body.
• Some studies have explored the potential of natural remedies like St. John's Wort and N-acetylcysteine for nicotine addiction treatment, with mixed results.
• The cholinergic anti-inflammatory pathway, which involves the alpha7 subunit of the nicotinic acetylcholine receptor, is significant in managing obesity-induced inflammation and insulin resistance.
• Nicotine's role in diseases like ulcerative colitis has been studied, with some findings suggesting that it may have protective effects against the disease.

References:

1. Filter ventilation and nicotine content of tobacco in cigarettes from Canada, the United Kingdom, and the United States
2. Daily intake of nicotine during cigarette smoking
3. New sources of dietary myosmine uptake from cereals, fruits, vegetables, and milk
4. Determination of the nicotine content of various edible nightshades (Solanaceae) and their products and estimation of the associated dietary nicotine intake
5. Mouth versus deep airways absorption of nicotine in cigarette smokers
6. A consideration of the role of gas/particle partitioning in the deposition of nicotine and other tobacco smoke compounds in the respiratory tract
7. Absorption of nicotine from small cigars
8. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum
9. A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler
10. Determinants of nicotine intake while chewing nicotine polacrilex gum
11. A pharmacokinetic crossover study to compare the absorption characteristics of three transdermal nicotine patches
12. Clinical pharmacology of inhaled drugs of abuse: implications in understanding nicotine dependence
13. Metabolism and disposition kinetics of nicotine
14. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man
15. Effect of smoking history on [3H]nicotine binding in human postmortem brain
16. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies
17. Transdermally administered nicotine accumulates in gastric juice
18. Nicotine and cotinine concentrations in the nursing mother and her infant
19. Risks and benefits of nicotine to aid smoking cessation in pregnancy
20. Nicotine delivery kinetics and abuse liability
21. Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons
22. Reinvestigation of the synthesis and evaluation of [N-methyl-(11)C]vorozole, a radiotracer targeting cytochrome P450 aromatase
23. Unique distribution of aromatase in the human brain: in vivo studies with PET and [N-methyl-11C]vorozole
24. Metabolism of nicotine to cotinine studied by a dual stable isotope method
25. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine
26. Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3'-hydroxycotinine in smokers
27. Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N'-oxide
28. Stereoselective metabolism of (S)-(-)-nicotine in humans: formation of trans-(S)-(-)-nicotine N-1'-oxide
29. Biotransformation of primary nicotine metabolites: metabolism of R-(+)-[3H-N'-CH3; 14C-N-CH3] N-methylnicotinium acetate--the use of double isotope studies to determine the in-vivo stability of the N-methyl groups of N-methylnicotinium ion
30. Inhibition of human aromatase by myosmine
31. Adrenal-mediated rather than direct effects of nicotine as a basis of altered sex steroid synthesis in fetal and neonatal rat
32. Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro
33. Aromatase inhibitors in cigarette smoke, tobacco leaves and other plants
34. Competitive inhibition of human placental aromatase by N-n-octanoylnornicotine and other nornicotine derivatives
35. Tobacco alkaloid derivatives as inhibitors of breast cancer aromatase
36. Potential contribution of aromatase inhibition to the effects of nicotine and related compounds on the brain
37. Nicotine-induced limbic cortical activation in the human brain: a functional MRI study
38. Meta-analysis of the acute effects of nicotine and smoking on human performance
39. What aspects of human performance are truly enhanced by nicotine?
40. A single dose of nicotine enhances reward responsiveness in nonsmokers: implications for development of dependence
41. Nicotine has calming effects on stress-induced mood changes in females, but enhances aggressive mood in males
42. Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers
43. The effects of nicotine and sucrose on spatial memory and attention
44. Cigarette abstinence impairs memory and metacognition despite administration of 2 mg nicotine gum
45. Cognitive mechanisms of nicotine on visual attention
46. Transdermal nicotine effects on attention
47. Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray
48. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits
49. Nicotine modulates reorienting of visuospatial attention and neural activity in human parietal cortex
50. Smoking, processing speed and attention in a choice reaction time task
51. The effects of nicotine on attention and working memory in never-smokers
52. A low dose of subcutaneous nicotine improves information processing in non-smokers
53. Nicotine effects on retrieval-induced forgetting are not attributable to changes in arousal
54. Smoking history and nicotine effects on cognitive performance
55. Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network
56. Tolerance to repeated nicotine administration on performance, subjective, and physiological responses in nonsmokers
57. Nicotine improves antisaccade task performance without affecting prosaccades
58. Behavioral and neural effects of nicotine on visuospatial attentional reorienting in non-smoking subjects
59. Effects of nicotine on visuo-spatial selective attention as indexed by event-related potentials
60. Effects of the cholinergic agonist nicotine on reorienting of visual spatial attention and top-down attentional control
61. Performance effects of nicotine during selective attention, divided attention, and simple stimulus detection: an fMRI study
62. Nicotine effects on alertness and spatial attention in non-smokers
63. Caffeine, but not nicotine, enhances visual feature binding
64. Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial
65. Nicotine increases neural response to unpleasant stimuli and anxiety in non-smokers
66. The effects of cigarette smoking on human sexual potency
67. Acute effects of nicotine on physiological and subjective sexual arousal in nonsmoking men: a randomized, double-blind, placebo-controlled trial
68. The inhibitory effects of nicotine on physiological sexual arousal in nonsmoking women: results from a randomized, double-blind, placebo-controlled, cross-over trial
69. Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity
70. A double-blind placebo controlled experimental study of nicotine: I--effects on incentive motivation
71. Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity
72. Dramatic decreases in brain reward function during nicotine withdrawal
73. The effects of acute doses of nicotine on video lottery terminal gambling in daily smokers
74. Nicotine addiction and comorbidity with alcohol abuse and mental illness
75. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
76. Dual effects of nicotine on dopamine neurons mediated by different nicotinic receptor subtypes
77. N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens
78. Nicotine activates and desensitizes midbrain dopamine neurons
79. Role of dopamine in the behavioural actions of nicotine related to addiction
80. Neurobiology of nicotine addiction: implications for smoking cessation treatment
81. Laterodorsal tegmental projections to identified cell populations in the rat ventral tegmental area
82. Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction
83. Cellular and synaptic mechanisms of nicotine addiction
84. Long-term potentiation of excitatory inputs to brain reward areas by nicotine
85. Cholinergic axon terminals in the ventral tegmental area target a subpopulation of neurons expressing low levels of the dopamine transporter
86. Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study
87. The acute effects of nicotine on the subjective and behavioural responses to denicotinized tobacco in dependent smokers
88. The effects of nicotine, denicotinized tobacco, and nicotine-containing tobacco on cigarette craving, withdrawal, and self-administration in male and female smokers
89. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine
90. Arterial/venous plasma nicotine concentrations following nicotine nasal spray
91. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?
92. Smoking cessation in women. Special considerations
93. Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administration
94. Sex differences in the contribution of nicotine and nonpharmacological stimuli to nicotine self-administration in rats
95. Nicotine self-administration in rats: estrous cycle effects, sex differences and nicotinic receptor binding
96. Using growth models to relate acquisition of nicotine self-administration to break point and nicotinic receptor binding
97. Sex and ovarian hormones influence vulnerability and motivation for nicotine during adolescence in rats
98. Progesterone treatment during the early follicular phase of the menstrual cycle: effects on smoking behavior in women
99. Symptomatology across the menstrual cycle in smoking and nonsmoking women
100. Cigarette smoking by women: interactions with alcohol use
101. Smoking behavior, dysphoric states and the menstrual cycle: results from single smoking sessions and the natural environment
102. Effects of menstrual phase on reactivity to nicotine
103. Effects of menstrual phase on nicotine, alcohol, and caffeine intake in smokers
104. Effects of menstrual phase and smoking abstinence in smokers with and without a history of major depressive disorder
105. Retrospective study: influence of menstrual cycle on cue-induced cigarette craving
106. Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a review
107. Nicotine addiction causes unique detrimental effects on women's brains
108. Beneficial effects of nicotine: fact or fiction?
109. Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance
110. Smoking induces insulin resistance--a potential link with the insulin resistance syndrome
111. Acute effects of nicotine on serum glucose insulin growth hormone and cortisol in healthy smokers
112. Nicotine infusion acutely impairs insulin sensitivity in type 2 diabetic patients but not in healthy subjects
113. Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus
114. Interventions for preventing weight gain after smoking cessation
115. Weight gain and cardiovascular risk factors during smoking cessation with bupropion or nicotine
116. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events
117. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers
118. Changes in circulating lipid and carbohydrate metabolites following systemic nicotine treatment in healthy men
119. The impact of cigarette and alcohol consumption on weight and obesity. An analysis of 1911 monozygotic male twin pairs
120. Cholinoceptor-mediated effects on glycerol output from human adipose tissue using in situ microdialysis
121. Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 adipocytes: a role for oxidant stress
122. Systemic nicotine stimulates human adipose tissue lipolysis through local cholinergic and catecholaminergic receptors
123. The nicotinic acetylcholine receptor α7 in subcutaneous mature adipocytes: downregulation in human obesity and modulation by diet-induced weight loss
124. Effect of chewing gum containing nicotine and caffeine on energy expenditure and substrate utilization in men
125. Effect of nicotine on body composition in mice
126. Nicotine-induced weight loss in rats without an effect on appetite
127. Effects of nicotine on body weight, food consumption and body composition in male rats
128. No acute effects of smoking and nicotine nasal spray on lipolysis measured by subcutaneous microdialysis
129. Effects of cigarette smoke and nicotine on feeding and energy
130. Alterations of lipolysis and lipoprotein lipase in chronically nicotine-treated rats
131. Increased 24-hour energy expenditure in cigarette smokers
132. Pharmacodynamics of acute tolerance to multiple nicotinic effects in humans
133. National working conference on smoking and body weight. Task Force 1: Mechanisms relevant to the relations between cigarette smoking and body weight
134. Weight gain following smoking cessation: a possible role for nicotine replacement in weight management
135. Effects of tobacco smoking on caloric intake
136. Attitudes toward smoking cessation among men and women
137. Smoking cessation in women concerned about weight
138. Effect of nicotine chewing gum in smoking cessation. A randomized, placebo-controlled, double-blind study
139. Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking
140. Effects of differing nicotine-replacement doses on weight gain after smoking cessation
141. Weight change after smoking cessation using variable doses of transdermal nicotine replacement
142. Interventions for preventing weight gain after smoking cessation
143. Novel and reversible mechanisms of smoking-induced insulin resistance in humans
144. Raptor binds the SAIN (Shc and IRS-1 NPXY binding) domain of insulin receptor substrate-1 (IRS-1) and regulates the phosphorylation of IRS-1 at Ser-636/639 by mTOR
145. Anti-inflammatory effects of nicotine in obesity and ulcerative colitis
146. Enhanced serum antigen-specific IgG1 and proinflammatory cytokine production in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice
147. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation
148. It takes nerve to dampen inflammation
149. Nicotine blocks TNF-alpha-mediated neuroprotection to NMDA by an alpha-bungarotoxin-sensitive pathway
150. Autonomic neural regulation of immunity
151. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis
152. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
153. Tristetraprolin mediates anti-inflammatory effects of nicotine in lipopolysaccharide-stimulated macrophages
154. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency
155. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
156. Physiology and immunology of the cholinergic antiinflammatory pathway
157. Risk of ulcerative colitis among former and current cigarette smokers
158. Is smoking an indirect risk factor for the development of ulcerative colitis? An age- and sex-matched case-control study
159. Cigarette smoking and ulcerative colitis: a case-control study
160. Lack of association between smoking and Crohn's disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study
161. In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis
162. Lack of association between smoking and inflammatory bowel disease in Jewish patients in Israel
163. Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine
164. Mechanisms of disease: nicotine--a review of its actions in the context of gastrointestinal disease
165. Transdermal nicotine for active ulcerative colitis
166. Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users
167. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation
168. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells
169. Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways
170. The modulating role of nuclear factor-kappaB in the action of alpha7-nicotinic acetylcholine receptor and cross-talk between 5-lipoxygenase and cyclooxygenase-2 in colon cancer growth induced by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
171. Activation of 5-lipoxygenase is required for nicotine mediated epithelial-mesenchymal transition and tumor cell growth
172. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines
173. Role of the non-neuronal human cholinergic system in lung cancer and mesothelioma: possibility of new therapeutic strategies
174. Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma
175. Nicotine toxicity to the ultrastructure of the testis in rats
176. Immunolocalization of androgen and oestrogen receptors in the ventral lobe of rat (Rattus norvegicus) prostate after long-term treatment with ethanol and nicotine
177. Inhibitory role of cholinergic agonists on testosterone secretion by purified rat Leydig cells
178. Nicotine and cotinine inhibit steroidogenesis in mouse Leydig cells
179. Effects of oral administration of nicotine on organ weight, serum testosterone level and testicular histology in adult male rats
180. Nicotine diminishes testicular gametogenesis, steroidogenesis, and steroidogenic acute regulatory protein expression in adult albino rats: possible influence on pituitary gonadotropins and alteration of testicular antioxidant status
181. Morphological alterations in the prostate stroma of rats submitted to chronic nicotine treatment
182. Morphometric and morphological features of the ventral prostate in rats submitted to chronic nicotine and alcohol treatment
183. Effects of intravenous cocaine and cigarette smoking on luteinizing hormone, testosterone, and prolactin in men
184. Relationship of smoking cessation and nicotine gum use to salivary androstenedione and testosterone in middle-aged men
185. Relationship between testosterone serum levels and lifestyle in aging men
186. Cigarette smoking and serum sex hormones in men
187. The association of testosterone with nicotine use in young adult females
188. The interaction of sociological and biological factors in adolescent cigarette smoking
189. Nicotine inhibits pulsatile luteinizing hormone secretion in human males but not in human females, and tolerance to this nicotine effect is lost within one week of quitting smoking
190. Smoke alarm: a review of the clinical impact of smoking on women
191. Osteoporosis and smoking
192. Nicotine and estrogen synergistically exacerbate cerebral ischemic injury
193. Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1
194. Chronic nicotine exposure inhibits 17beta-estradiol-mediated protection of the hippocampal CA1 region against cerebral ischemia in female rats
195. Nicotine administration to rats: methodological considerations
196. Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation
197. Estrogen receptors: how do they signal and what are their targets
198. Synergistic inhibitory effect of nicotine plus oral contraceptive on mitochondrial complex-IV is mediated by estrogen receptor-β in female rats
199. Chronic nicotine exposure inhibits estrogen-mediated synaptic functions in hippocampus of female rats
200. Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal
201. Tobacco, alcohol, and caffeine use: a review of their interrelationships
202. Acute thermogenic effects of nicotine combined with caffeine during light physical activity in male and female smokers
203. The appetite-suppressant effect of nicotine is enhanced by caffeine
204. Effects of oral caffeine pretreatment on response to intravenous nicotine and cocaine
205. Caffeine's influence on nicotine's effects in nonsmokers
206. The influence of caffeine on nicotine's discriminative stimulus, subjective, and reinforcing effects
207. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers
208. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers
209. Alcohol consumption, alcohol dependence, and all-cause mortality
210. Sex differences in the acute effects of cigarette smoking on the reinforcing value of alcohol
211. Nicotine increases alcohol self-administration in non-dependent male smokers
212. Preliminary findings on the interactive effects of IV ethanol and IV nicotine on human behavior and cognition: a laboratory study
213. Psychopharmacological interactions between nicotine and ethanol
214. Pretreatment with transdermal nicotine enhances some of ethanol's acute effects in men
215. Separate and combined effects of the social drugs on psychomotor performance
216. Nicotine-alcohol interactions and cognitive function in rats
217. Dissociable effects of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior
218. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse
219. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats
220. N-acetyl cysteine-induced blockade of cocaine-induced reinstatement
221. Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study
222. The role of cystine-glutamate exchange in nicotine dependence in rats and humans
223. Hypericum perforatum attenuates nicotine withdrawal signs in mice
224. A Phase II study of St. John's Wort for smoking cessation
225. A randomized clinical trial of St. John's wort for smoking cessation
226. A placebo-controlled trial of modafinil for nicotine dependence
227. Immunohistochemical localization of taurine in the male reproductive organs of the rat
228. Taurine treatment protects against chronic nicotine-induced oxidative changes
229. Protective effects of taurine against nicotine-induced oxidative damage of rat urinary bladder and kidney
230. Female sex and oral contraceptive use accelerate nicotine metabolism

Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!